| Groups | OR (95 % CI) | Test of significance | ||
Group A HTN with LVH (N = 25) | Group B HTN without LVH (N = 25) | ||||
XRCC3 | Thr/Met | 12 (48%) | 4 (16%) |
| p = 0.015* |
Thr/Thr | 13 (52%) | 21 (84%) | 2.86 (1.98 - 3.85) | ||
Alleles | Thr Met | 38 (76%) 12 (24%) | 46 (92%) 4 (8%) | 3.22 (1.13 - 5.35) | 0.03* |